[go: up one dir, main page]

DE68900548D1 - Konzentrierte corticosteroide enthaltende loesungen und verfahren zu deren herstellung. - Google Patents

Konzentrierte corticosteroide enthaltende loesungen und verfahren zu deren herstellung.

Info

Publication number
DE68900548D1
DE68900548D1 DE8989100413T DE68900548T DE68900548D1 DE 68900548 D1 DE68900548 D1 DE 68900548D1 DE 8989100413 T DE8989100413 T DE 8989100413T DE 68900548 T DE68900548 T DE 68900548T DE 68900548 D1 DE68900548 D1 DE 68900548D1
Authority
DE
Germany
Prior art keywords
surfactant
production
corticosteroid
solutions containing
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989100413T
Other languages
English (en)
Inventor
Donna K C O Schwarz P Multhauf
Sudhakar S Dr Wagle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma GmbH
Original Assignee
Schwarz Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwarz Pharma AG filed Critical Schwarz Pharma AG
Application granted granted Critical
Publication of DE68900548D1 publication Critical patent/DE68900548D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE8989100413T 1988-01-13 1989-01-11 Konzentrierte corticosteroide enthaltende loesungen und verfahren zu deren herstellung. Expired - Lifetime DE68900548D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14357988A 1988-01-13 1988-01-13

Publications (1)

Publication Number Publication Date
DE68900548D1 true DE68900548D1 (de) 1992-01-30

Family

ID=22504674

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989100413T Expired - Lifetime DE68900548D1 (de) 1988-01-13 1989-01-11 Konzentrierte corticosteroide enthaltende loesungen und verfahren zu deren herstellung.

Country Status (5)

Country Link
EP (1) EP0325949B1 (de)
AT (1) ATE70446T1 (de)
DE (1) DE68900548D1 (de)
ES (1) ES2038344T3 (de)
GR (1) GR3003623T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
EA010885B1 (ru) 2003-12-08 2008-12-30 Бентли Фармасьютикалз, Инк. Фармацевтические композиции и способы лечения инсулином
FR2911781B1 (fr) 2007-01-26 2009-03-20 Fabre Pierre Dermo Cosmetique Emulsion dermatologique et procede de preparation
WO2012158405A2 (en) * 2011-05-16 2012-11-22 Pearlman Dale L Compositions and methods for the treatment of skin diseases
US9861645B2 (en) 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US4360518A (en) * 1979-08-06 1982-11-23 Johnson & Johnson Topical anti-inflammatory drug therapy
US4863912A (en) * 1986-05-19 1989-09-05 New York Medical College Use of tetrahydrocortisol in glaucoma therapy

Also Published As

Publication number Publication date
EP0325949B1 (de) 1991-12-18
EP0325949A1 (de) 1989-08-02
ATE70446T1 (de) 1992-01-15
GR3003623T3 (de) 1993-03-16
ES2038344T3 (es) 1993-07-16

Similar Documents

Publication Publication Date Title
HUT34891A (en) Process for producing compositions with controlled dissolution of active ingredients
DE68900548D1 (de) Konzentrierte corticosteroide enthaltende loesungen und verfahren zu deren herstellung.
JPS54160740A (en) Anti-fibrotic agent
ATE39599T1 (de) Verfahren zur herstellung von pflanzenschutzmittel-dispersionen.
HU179483B (en) Herbicide and fungicide compositions containing phenoxy-propionic acid derivatives as active agents,and process for producing phenoxy-propionic acid derivatives
ATE31002T1 (de) Verfahren zur herstellung von fluessigen pflanzenschutzmittelkombinationen.
AT281842B (de) Verfahren zur herstellung von neuen 10,11-dihydro-di-benzo <b,f>-azepinderivaten sowie von deren saeureadditionssalzen und quaternaeren ammoniumverbindungen
MX9806218A (es) Procedimiento para hacer una composicion suavizante de tela, liquida, estable y fluida, que incluye poliolefina dispersable.
ATA163577A (de) Verfahren zur herstellung von neuen 3-aminomethyl-2-phenylbicyclo (2,2,2) octanen und -octenen sowie deren saureadditionssalzen
ES8601356A1 (es) Procedimiento para la obtencion de un agente liquido, homogeneo para el tratamiento de la colada
DE3162067D1 (en) Plant-growth regulating compositions containing as active agent 2-methylene-succinamic acid derivatives, and derivatives of this acid useful in these compositions
CH513164A (de) Verfahren zur Herstellung neuer 1-Alkyl-1,2,5,6-tetrahydro-3-pyridylmethyl-carbonsäureester sowie von deren Säureadditionssalzen und deren Verwendung zur Herstellung ihrer quaternären Ammoniumverbindungen
DE2966607D1 (en) Medicines containing as active ingredients compounds of the benzene-sulfone type; compounds of this type and process for their preparation
DE2965912D1 (en) Medicines containing as active ingredients compounds of the benzene-sulfone type; compounds of this type and process for their preparation
JPS5359674A (en) 1-piperidinoalkane-1,1-diphosphonic acid derivatives and herbicidescontaining the same as active agent
JPS5535017A (en) Beta-nitrostyrene derivative
AT301556B (de) Verfahren zur Herstellung von neuen 10,11-Dihydro-dibenzo[b,f]azepinderivaten sowie von deren Säureadditionssalzen und quaternären Ammoniumderivaten
HU175951B (en) Herbicide compositions containing phenoxy-phenoxy-crotonoic acid, and process for producing the active agents
AT352136B (de) Verfahren zur herstellung von neuen 1,5,10,10a- tetrahydrothiazolo-(3,4-b) -isochinolin-derivaten und von deren saeure- additionssalzen
BE899278A (fr) Agent antimycotique a haute liberation de substance active sous forme d'une creme.
DE2961478D1 (en) Process for the preparation of 2,4-dinitrophenyl urea
JPS5268164A (en) Preparation of 8(14)-dihydropimaric acid
IT7826498A0 (it) Processo per la preparazione di derivati dell'acido benzoxazolilpropionico.
AT318563B (de) Verfahren zur Herstellung von neuen 1-Amino-2-hydroxy-3-(1',4'-methano- bzw. 1',4'-äthanotetrahydronaphthyloxy)-propanen sowie deren Säureadditionssalzen
JPS57107825A (en) Manufacture of crosslinked organic macromolecular long body

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8330 Complete renunciation